Linden Thomas Advisory Services LLC cut its position in Innospec Inc. (NASDAQ:IOSP – Free Report) by 1.6% during the second quarter, Holdings Channel.com reports. The institutional investor owned 11,736 shares of the specialty chemicals company’s stock after selling 190 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in Innospec were worth $987,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Principal Financial Group Inc. boosted its position in Innospec by 2.4% in the first quarter. Principal Financial Group Inc. now owns 132,493 shares of the specialty chemicals company’s stock valued at $12,554,000 after buying an additional 3,045 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Innospec during the second quarter worth approximately $345,000. American Century Companies Inc. lifted its position in shares of Innospec by 27.7% during the first quarter. American Century Companies Inc. now owns 47,545 shares of the specialty chemicals company’s stock worth $4,505,000 after purchasing an additional 10,309 shares in the last quarter. Voya Investment Management LLC lifted its position in shares of Innospec by 63.2% during the first quarter. Voya Investment Management LLC now owns 327,289 shares of the specialty chemicals company’s stock worth $31,011,000 after purchasing an additional 126,750 shares in the last quarter. Finally, Intech Investment Management LLC lifted its position in shares of Innospec by 30.7% during the first quarter. Intech Investment Management LLC now owns 22,023 shares of the specialty chemicals company’s stock worth $2,087,000 after purchasing an additional 5,178 shares in the last quarter. 96.64% of the stock is currently owned by institutional investors and hedge funds.
Innospec Price Performance
IOSP opened at $76.31 on Monday. The company has a market cap of $1.89 billion, a price-to-earnings ratio of 97.83 and a beta of 1.04. The firm has a 50 day simple moving average of $80.55 and a 200 day simple moving average of $84.18. Innospec Inc. has a fifty-two week low of $73.39 and a fifty-two week high of $128.35.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on IOSP. Wall Street Zen lowered shares of Innospec from a “buy” rating to a “hold” rating in a research report on Sunday, October 19th. Zacks Research upgraded shares of Innospec from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Finally, Weiss Ratings lowered Innospec from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold”.
View Our Latest Report on IOSP
About Innospec
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Recommended Stories
- Five stocks we like better than Innospec
- 3 Warren Buffett Stocks to Buy Now
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- How Can Investors Benefit From After-Hours Trading
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- Using the MarketBeat Stock Split Calculator
- Is Landstar the Next Big Winner in Transportation Stocks?
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.
